Joint Stock Company National Immunobiological Company was established on October 29, 2013 with the goal of creating a holding company (integrated structure) of the State Corporation “Rosteh” in the development and production of immunobiological products.
The Holding ensures the independence of the Russian Federation from imports in the health care system and drug provision by developing its own production and scientific competencies. Immunobiological preparations and preparations for the treatment of infectious diseases are the main priority.
Natsimbio unites production enterprises, research and development centers. In cooperation with Russian and foreign companies, the holding carries out the production of the most important medicines, develops innovative products, and builds and equips newly created and modernized enterprises.